Functional vascular endothelial growth factor -634G>C SNP is associated with proliferative diabetic retinopathy: A case-control study in a Brazilian population of European ancestry

Diabetes Care

Volumn 30, Issue 2, 2007, Pages 275-279

  Errera, Flavia I V ^a,b   Canani, Luís Henrique ^c   Silva, Maria Elisabeth R ^a   Yeh, Erika ^a   Takahashi, Walter ^a   Santos, Katia G ^c   Souto, Katia E P ^d   Tschiedel, Balduíno ^d   Roisenberg, Israel ^c   Gross, Jorge Luis ^c   Passos Bueno, Maria Rita ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d Hospital N Sra Conceição   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VASCULOTROPIN;

ADULT; ARTICLE; BODY MASS; BRAZIL; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC RETINOPATHY; DISEASE DURATION; EUROPE; FEMALE; GENOTYPE; HEREDITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROLIFERATIVE RETINOPATHY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; BRAZIL; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPIDS; MALE; MIDDLE AGED; PHYSICAL EXAMINATION; POLYMORPHISM, SINGLE NUCLEOTIDE; QUESTIONNAIRES; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846682260     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1399     Document Type: Article

References (29)

1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527-532, 1984
2. Rema M, Saravanan G, Deepa R, Mohan V: Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet Med 19:910-916, 2002
3. Hallman DM, Huber JC Jr, Gonzalez VH, Klein BE, Klein R, Hanis CL: Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care 28:1163-1168, 2005
4. Kohner EM: Diabetic retinopathy. BMJ 6:1195-1199, 1993.
5. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 25:983-985, 1983
6. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 8:1309-1312, 1989
7. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 10:576-579, 1994
8. Cooper ME, Vranes D, Youssef S, Stacker SA, Cox AJ, Rizkalla B, Casley DJ, Bach LA, Kelly DJ, Gilbert RE: Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48:2229-2239, 1999
9. Sone H, Kawakami Y, Okuda Y, Kondo S, Hanatani M, Suzuki H, Yamashita K: Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 5:193-198, 1996
10. Aiello LP: Clinical implications of vascular growth factors in proliferative retinopathies. Curr Opin Ophthalmol 8:19-31, 1997
11. Funatsu H, Yamashita H, Noma H, Mochizuki H, Mimura T, Ikeda T, Hori S: Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin. Invest Ophthalmol Vis Sci 44:1042-1047, 2003
12. Funatsu H, Yamashita H, Mimura T, Noma H, Nakamura S, Hori S: Risk evaluation of outcome of vitreous surgery based on vitreous levels of cytokines. Eye. In press
13. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K, Inoue I, Katayama S: A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:1635-1639, 2002.
14. Yang B, Cross DF, Ollerenshaw M, Millward BA, Demaine AG: Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus. J Diabetes Complications 17:1-6, 2003
15. Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P: Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 53:861-864, 2004
16. Awata T, Kurihara S, Takata N, Neda T, Iizuka H, Ohkubo T, Osaki M, Watanabe M, Nakashima Y, Inukai K, Inoue I, Kawasaki I, Mori K, Yoneya S, Katayama S: Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun 5: 679-685, 2005
17. Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P: VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34:383-394, 2003
18. Lambrechts D, Devriendt K, Driscoll DA, Goldmuntz E, Gewillig M, Vlietinck R, Collen D, Carmeliet P: Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study. J Med Genet 42:519-522, 2005
19. Canani LH, Capp C, Ng DP, Choo SG, Maia AL, Nabinger GB, Santos K, Crispim D, Roisemberg I, Krolewski AS, Gross JL: The fatty acid-binding protein-2 A54T polymorphism is associated with renal disease in patient with type 2 diabetes. Diabetes 4:3326-3330, 2005
20. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 28:S37-S42, 2005
21. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413-2446, 1997
22. Diabetic Retinopathy Study Research Group; Report VII: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 21:210-226, 1981
23. American Academy of Ophthalmology: Diabetic Retinopathy Disease Severity Scale [online]. Available from http://www.aao.org/education/library/ recommendations/international_dr.cfm. Accessed 3 July 2006
24. Beranek M, Kankova K, Benes P, Izakovicova-Holla L, Znojil V, Hajek D, Vlkova E, Vacha J: Polymorphism R25P in the gene encoding transforming growth factor-β (TGF-β1) is a newly identified risk factor for proliferative diabetic retinopathy. Am J Med Genet 15:278-283, 2002
25. Taverna MJ, Elgrably F, Selmi H, Selam JL, Slama G: The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy. Nitric Oxide 13:88-92, 2005
26. dos Santos KG, Canani LH, Gross JL, Tschiedel B, Pires Souto KE, Roisenberg I: The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes. Mol Genet Metab 85:149-156, 2005
27. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
28. Bornes S, Boulard M, Hieblot C, Zanibellato C, Iacovoni JS, Prats H, Touriol C: Control of the vascular endothelial growth factor internal ribosome entry site (IRES) activity and translation initiation by alternatively spliced coding sequences. J Biol Chem 30:18717-18726, 2004
29. Huez I, Bornes S, Bresson D, Creancier L, Prats H: New vascular endothelial growth factor isoform generated by internal ribosome entry site-driven CUG translation initiation. Mol Endocrinol 15:2197-210, 2001